The power of R&D collaborations to improve outcomes in rare diseases

Far more common than initially thought, rare disease treatments remain far too scarce. The answer to the problem, of course, lays in making medical research more effective.

A key step towards this is great collaborative working, and partnerships with the likes of the European reference networks and French healthcare network G2M are crucial to success.

Read the source article at pharmaphorum.com
2021-10-07 15:39:16